Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$171,339,000
-$14,583,000 QoQ
Shares Held
700,000
-36.4% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
2.61%
of 13F equity value
Holder Rank
#9
of 503 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Sep 30, 2024CallValue
$17,974,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. AXSM ranks #14 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in AXSM
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,339,000 | 700,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $185,922,000 | 1,100,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $210,036,000 | 1,150,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $109,305,000 | 900,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $83,655,118 | 801,371 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $77,038,271 | 857,219 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $17,974,000 | 200,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $149,149,112 | 1,852,784 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $104,116,735 | 1,304,721 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $79,590,000 | 1,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $79,726,668 | 1,140,745 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,608,612 | 384,200 | Shares | Sole | 2023-09-06 | |
| No filing history on record for this holder in this stock. | ||||||